Published • loading... • Updated
Aptar Pharma and COVIRIX Medical Partner to Develop Inhalable Antiviral Treatments
Summary by 01net
1 Articles
1 Articles
Aptar Pharma and COVIRIX Medical Partner to Develop Inhalable Antiviral Treatments
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Pharma, a global leader in drug delivery, dosing, protection technologies and services, today announced a technical collaboration with COVIRIX Medical Pty Ltd (“COVIRIX Medical”), an Australian biopharma compa... L'articolo Aptar Pharma and COVIRIX Medical Partner to Develop Inhalable Antiviral Treatments è un contenuto originale di 01net.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium